686 Results

People

  1. Giralt
    Giralt
  2. Usmani
    Usmani
  3. Landgren
    Landgren
  4. Lesokhin
    Lesokhin
  5. Landau
    Landau
  6. Mailankody
    Mailankody
  7. Hassoun
    Hassoun
  8. Hultcrantz
    Hultcrantz
  9. Shah
    Shah
  10. Shah
    Shah

Groups

  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)
  7. Survivorship Research (127)
  8. Sloan Kettering Institute Postdocs (86)
  9. GSK Faculty (76)
  10. Epidemiology and Biostatistics (65)
  1. "multiple myeloma"
Formats
  1. Journal Article (519)
  2. Review (86)
  3. Research Letter (23)
  4. Editorial (17)
  5. Meeting Abstract (15)
  6. Book Section (10)
  7. Correspondence (7)
  8. Guidelines (6)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)

More Groups

People
  1. Sergio Giralt (95)
  2. Saad Usmani (77)
  3. Carl Landgren (76)
  4. Alexander Lesokhin (66)
  5. Heather Landau (55)
  6. Sham Mailankody (55)

More People

Years
  1. 2025 (34)
  2. 2024 (83)
  3. 2023 (85)
  4. 2022 (49)
  5. 2021 (25)
  6. 2020 (47)

More Years

Publications
  1. Blood (37)
  2. Clinical Lymphoma, Myeloma and Leukemia (34)
  3. Biology of Blood and Marrow Transplantation (33)
  4. Leukemia and Lymphoma (21)
  5. Blood Cancer Journal (20)
  6. British Journal of Haematology (20)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Nature Publishing Group (84)
  3. American Society of Hematology (48)
  4. Springer (34)
  5. John Wiley & Sons (30)
  6. Taylor & Francis Group (26)

More Publishers

Results (686)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States
    Research Letter

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O’Byrne, L.; Happ, L. P.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • High WEE1 expression is independently linked to poor survival in multiple myeloma
    Journal Article

    Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Avutu, V.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/ DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
    Research Letter

    Lewis, N. E.; Petrova-Drus, K.; Sardana, R.; Huet, S.; Gao, Q.; Sethi, S.; Vanderbilt, C.; Xiao, W.; Roshal, M.; Baik, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
    Journal Article

    Bhutani, M.; Robinson, M.; Foureau, D.; Atrash, S.; Paul, B.; Guo, F.; Grayson, J. M.; Ivanina-Foureau, A.; Pineda-Roman, M.; Varga, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • The landscape of clinical trials for heavily pretreated multiple myeloma: Opportunity for more randomization?
    Correspondence

    Kapur, R.; McCarron, J.; Rajeeve, S.; Mohyuddin, G. R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save